SOBI:STO
Swedish Orphan Biovitrum AB (publ)
427,20Â SEK
arrow_downward
-1,48%(-6,40) 1K
13-okt, 17:29:57 (GMT+2) · SEK
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoSOBI tikeri uchun statistika yaratilmoqda...
Ochish
433,60Â SEK
Yuqori
437,40Â SEK
Past
420,40Â SEK
Bozor kapitali
152,78Â mlrd
Oʻrtacha hajm
269,95Â ming
Hajmi
332,11Â ming
P/E koeffitsiyenti
114,10
52 haftalik eng yuqori
487,00Â SEK
52 haftalik eng past
293,60Â SEK
Aksiya boʻyicha daromad
3,74Â SEK
Muomaladagi aksiyalar
357,64Â mln
Xodimlar soni
2Â ming
Ochish
433,60Â SEK
Yuqori
437,40Â SEK
Past
420,40Â SEK
Bozor kapitali
152,78Â mlrd
Oʻrtacha hajm
269,95Â ming
Hajmi
332,11Â ming
P/E koeffitsiyenti
114,10
52 haftalik eng yuqori
487,00Â SEK
52 haftalik eng past
293,60Â SEK
Aksiya boʻyicha daromad
3,74Â SEK
Muomaladagi aksiyalar
357,64Â mln
Xodimlar soni
2Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
Dow, S&P 500, Nasdaq Futures Mixed Amid Rising Oil Prices Ahead Of CPI Data: BAC, RIVN, SLS, GME Stocks In Focus
Simply Wall Street
·
5 daqiqa oldin
What Fortrea Holders Bought Into Before A 119% Run
WXXV News 25
·
56 daqiqa oldin
US stocks edge back from their record following the first big batch of profit reports for the summer
Investor's Business Daily
·
51 daqiqa oldin
Tech Futures Rise: Meta, AMD Lead 5 Buys; ASML, CPI Inflation Due
Profil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Swedish Orphan Biovitrum AB (publ) haqida